HAP Trading, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
25,600
-2.3%
0.00%
Q3 2022$2,000
-60.0%
26,200
-7.7%
0.00%
Q2 2022$5,000
-61.5%
28,400
-18.4%
0.00%
-100.0%
Q1 2022$13,000
-23.5%
34,800
-23.2%
0.00%
Q4 2021$17,000
+142.9%
45,300
+71.6%
0.00%
Q3 2021$7,000
-78.8%
26,400
-19.5%
0.00%
-100.0%
Q2 2021$33,000
-55.4%
32,800
-6.8%
0.00%
-75.0%
Q1 2021$74,000
-73.2%
35,200
-61.9%
0.00%
-50.0%
Q4 2020$276,000
+190.5%
92,500
+43.2%
0.01%
+60.0%
Q3 2020$95,000
-26.4%
64,600
-9.9%
0.01%
-28.6%
Q2 2020$129,000
+316.1%
71,700
+10.1%
0.01%
+250.0%
Q4 2019$31,000
-66.7%
65,100
-36.6%
0.00%
-75.0%
Q3 2019$93,000
-33.6%
102,700
+25.2%
0.01%
-27.3%
Q2 2019$140,000
-50.2%
82,000
-4.0%
0.01%
-56.0%
Q1 2019$281,000
+8.5%
85,458
+278.7%
0.02%
+56.2%
Q4 2018$259,00022,567
-53.0%
0.02%
Q4 2016$0
-100.0%
48,0000.0%0.00%
Q3 2016$12,000
-72.1%
48,000
+3.7%
0.00%
-100.0%
Q2 2016$43,000
-43.4%
46,300
+0.7%
0.00%
-50.0%
Q1 2016$76,00046,0000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders